Viking Therapeutics Inc (VKTX)
72.88
+0.34
(+0.47%)
USD |
NASDAQ |
Nov 01, 16:00
73.42
+0.54
(+0.74%)
After-Hours: 20:00
Viking Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Quarterly) Benchmarks
Amgen Inc | 8.503B |
Eli Lilly and Co | 11.44B |
Pfizer Inc | 17.70B |
Structure Therapeutics Inc | -- |
Altimmune Inc | 0.005M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -24.94M |
Total Expenses (Quarterly) | 36.56M |
EPS Diluted (Quarterly) | -0.22 |
Enterprise Value | 7.191B |
Earnings Yield | -1.28% |